[Form 3] GILEAD SCIENCES, INC. Initial Statement of Beneficial Ownership

Rhea-AI Filing Summary

Erin E. Burkhart, identified as Senior Vice President, Controllership, filed an Initial Statement on Form 3 reporting her relationship to Gilead Sciences, Inc. (GILD). The event date requiring the statement is 09/22/2025. The filing discloses that no securities are beneficially owned by the reporting person as of the filing. The form indicates it was signed on behalf of Ms. Burkhart by Edward S. Son under power of attorney on 09/23/2025. This is a routine Section 16 initial disclosure showing officer status and no current ownership in the issuer.

Insights

Financial Analyst

TL;DR: Routine Form 3 shows officer appointment with no reported ownership; immaterial to near-term financial metrics.

This Form 3 records an officer-level reporting obligation for Gilead (GILD) with an event date of 09/22/2025. The key fact is the explicit statement that the reporting person beneficially owns no securities. For investors and analysts, this filing does not change company fundamentals, capital structure, or outstanding share counts. It primarily documents compliance with Section 16 reporting requirements and the officer's lack of current equity exposure.

Corporate Governance Expert

TL;DR: Compliance filing noting officer status and no beneficial ownership; standard disclosure with no governance concerns.

The document serves as an initial disclosure under federal securities rules for an officer (SVP, Controllership). The use of a power of attorney signature is noted, which is acceptable under filing procedures. Because the filing reports no securities owned, there are no immediate related-party transaction or insider trading implications to assess. This is a routine governance record.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Burkhart Erin

(Last) (First) (Middle)

333 LAKESIDE DRIVE

(Street)

FOSTER CITY CA 94404

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
09/22/2025

3. Issuer Name and Ticker or Trading Symbol
GILEAD SCIENCES, INC. [ GILD ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, Controllership

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

No securities are beneficially owned.

	/s/ Edward S. Son by Power of Attorney for Erin E. Burkhart	09/23/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did the Form 3 filed by Erin E. Burkhart for GILD report?

The Form 3 reported that Erin E. Burkhart, SVP Controllership, filed an initial statement and stated she beneficially owns no securities of Gilead Sciences.

When is the event date and filing/signature date on the Form 3?

The event date requiring the statement is 09/22/2025, and the form was signed by power of attorney on 09/23/2025.

What is Erin Burkhart's relationship to the issuer GILD?

She is reported as an Officer with the title SVP, Controllership and the Form 3 indicates officer status for Gilead Sciences.

Does this Form 3 disclose any insider transactions or holdings?

No. The filing explicitly states: No securities are beneficially owned, so there are no reported holdings or transactions on this Form 3.

Was the Form 3 signed directly by the reporting person?

The signature block shows it was signed by Edward S. Son by Power of Attorney for Erin E. Burkhart on 09/23/2025.